Mutual of America Capital Management LLC Raises Position in RadNet, Inc. (NASDAQ:RDNT)

Mutual of America Capital Management LLC lifted its stake in RadNet, Inc. (NASDAQ:RDNTGet Rating) by 10.9% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 6,718 shares of the medical research company’s stock after buying an additional 658 shares during the period. Mutual of America Capital Management LLC’s holdings in RadNet were worth $150,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently bought and sold shares of RDNT. Allspring Global Investments Holdings LLC purchased a new position in RadNet in the fourth quarter valued at about $590,000. Yousif Capital Management LLC purchased a new position in RadNet in the fourth quarter valued at about $1,273,000. Raymond James Trust N.A. purchased a new position in RadNet in the fourth quarter valued at about $2,907,000. Assenagon Asset Management S.A. boosted its holdings in RadNet by 63.5% in the fourth quarter. Assenagon Asset Management S.A. now owns 397,065 shares of the medical research company’s stock valued at $11,956,000 after purchasing an additional 154,275 shares during the last quarter. Finally, Zurcher Kantonalbank Zurich Cantonalbank boosted its holdings in RadNet by 45.1% in the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 6,765 shares of the medical research company’s stock valued at $204,000 after purchasing an additional 2,102 shares during the last quarter. Hedge funds and other institutional investors own 64.14% of the company’s stock.

RadNet Trading Up 1.2 %

Shares of RDNT opened at $20.58 on Wednesday. The stock has a 50-day moving average price of $18.93 and a 200 day moving average price of $21.07. RadNet, Inc. has a one year low of $16.44 and a one year high of $38.84. The company has a market capitalization of $1.16 billion, a P/E ratio of 62.36 and a beta of 1.75. The company has a debt-to-equity ratio of 1.76, a quick ratio of 0.76 and a current ratio of 0.76.

RadNet (NASDAQ:RDNTGet Rating) last announced its quarterly earnings data on Monday, May 9th. The medical research company reported ($0.15) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.02) by ($0.13). RadNet had a net margin of 1.36% and a return on equity of 6.82%. The firm had revenue of $341.80 million for the quarter, compared to analyst estimates of $333.46 million. During the same quarter in the previous year, the company earned $0.04 EPS. The company’s quarterly revenue was up 8.4% compared to the same quarter last year. Sell-side analysts forecast that RadNet, Inc. will post 0.2 EPS for the current fiscal year.

Insider Buying and Selling at RadNet

In other RadNet news, COO Norman R. Hames sold 10,000 shares of the company’s stock in a transaction that occurred on Wednesday, June 1st. The stock was sold at an average price of $20.53, for a total transaction of $205,300.00. Following the sale, the chief operating officer now owns 280,179 shares in the company, valued at $5,752,074.87. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Insiders have sold 20,900 shares of company stock worth $414,923 over the last quarter. 5.80% of the stock is owned by corporate insiders.

About RadNet

(Get Rating)

RadNet, Inc, together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services.

Recommended Stories

Institutional Ownership by Quarter for RadNet (NASDAQ:RDNT)

Want More Great Investing Ideas?

Receive News & Ratings for RadNet Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RadNet and related companies with MarketBeat.com's FREE daily email newsletter.